This article highlights clinical and economic factors associated with Demodex blepharitis as well as diagnostic complexities, limitations of traditional therapies, the safety and efficacy of the 1 FDA ...
AJMC®: Could you describe the current standard of care for Demodex blepharitis and how it has evolved? PERIMAN: The understanding and management of Demodex blepharitis have evolved quite a bit in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback